PharmaEssentia (6446 TW) stock market data APIs
NT$492.1831
6.46(1.3%)
as of September 16, 2025
Try our APIs with
free plan!
PharmaEssentia Financial Data Overview
Price chart is built with
Anychart
PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Prev. Close
492.1831
Open
498.6391
High
495.7539
Low
488.765
52 wk Range
395.5448-1329.5226
Market Cap
181 773 M
P/E Ratio
44.9269
Shares Outstanding
370 M
Revenue
12 635 M
EPS
2.24
Dividends (Yield)
0.002
Beta
-0.06
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with PharmaEssentia (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PharmaEssentia data using free add-ons & libraries
Get PharmaEssentia Fundamental Data
PharmaEssentia Fundamental data includes:
- Net Revenue: 12 635 M
- EBITDA: 3 594 M
- Earnings Per Share: 10
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 3.51
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PharmaEssentia News
New
High Growth Tech Stocks In Asia For September 2025
As global markets continue to react to potential interest rate cuts and the surge in artificial intelligence, Asian tech stocks have caught the attention of investors seeking high growth opportunities...
High Growth Tech Stocks To Watch In Asia September 2025
As the Asian markets continue to ride a wave of optimism fueled by advancements in artificial intelligence and robust liquidity conditions, investors are keenly observing the region's tech sector for ...
Top High Growth Tech Stocks in Asia
As global markets experience shifts with U.S. labor data influencing interest rate expectations and China's economic indicators pointing to a slowdown, the Asian tech sector remains a focal point for ...
Exploring Three High Growth Tech Stocks in Asia
Amidst a backdrop of global economic shifts, Asian markets have been navigating through a mix of optimism and caution, with China's stock markets recently experiencing volatility due to domestic liqui...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
